2026 Final Rate Announcement for MA and Final Part D Program Instructions

April 9, 2025

EGWP medicaid Medicare

On April 7, CMS released the Calendar Year (CY) 2026 MA and Part D Final Rate Announcement and the Final CY 2026 Medicare Part D Program Instructions. The Administration strongly defended its focus on fraud, waste, and abuse, while protecting beneficiaries. The final rate notice increases average payments to MA plans by 5.06% up from the proposed 2.23%. The primary driver of higher payments for 2026 is CMS’ projection of higher cost trends in fee-for-service (FFS), which reflects more recent data.

CMS also finalized various technical adjustments and risk adjustment policy changes that reduce payments, leading to rates that will likely remain below the cost of caring for seniors in 2026. As expected, CMS will complete the phase-in of the new MA risk adjustment model that began in 2024. CMS also finalized the method for “normalization,” which alters risk adjustment payments to reflect FFS risk score trends. The combined impact of these policies is an estimated reduction in payments of 3.01%, on average.

Separately, CMS did not raise the coding intensity adjustment above the minimum 5.91% required by statute. CMS will implement updates to the Part D risk adjustment models for CY 2026 reflecting changes by the IRA to the Part D benefit for CY 2026, including the continuation of the Manufacturer Discount Program, the updated out-of-pocket threshold, and negotiated prices for selected drugs under the Medicare Drug Price Negotiation Program.

CMS also indicated it would carefully evaluate the feasibility and timing of any future changes to base the risk adjustment model on MA encounter data rather than FFS data and acknowledged requests for an extended comment period and transparency if a new model is formally proposed. 

legislation

CMS Releases Final 2026 MA Policy and Technical Rule; Declines to Finalize Coverage of GLP-1s

On April 4, the Centers for Medicare & Medicaid Services (CMS) finalized the 2026 MA Policy and Technical Changes rule. Of note, CMS is not finalizing certain provisions from the proposed rule, most importantly the proposal requiring coverage of anti-obesity medications (AOMs) in both Medicare and Medicaid. CMS said that it may address these proposals […]
read more >

April 9, 2025

EGWP marketplace medicaid Medicare

legislation

Budget Reconciliation Process Continues with Senate Consideration of Revised House Resolution

On April 5, the Senate voted 51-48 to pass a modified version of the House-passed budget resolution with reduced deficit reduction targets for Senate committees as compared to the House. Specific to health care, the revised Senate resolution instructs the Senate Finance Committee (SFC), which has jurisdiction over Medicaid, to propose changes that will increase […]
read more >

April 9, 2025

medicaid

legislation

Senate Finance Committee Advances Dr. Oz’s Nomination for CMS Administrator

On March 25, the Senate Finance Committee voted 14-13 along party lines to advance the nomination of Dr. Mehmet Oz as CMS Administrator. During the confirmation hearing, Chair Mike Crapo (R-ID) and other Republicans expressed strong support for Dr. Oz, citing his prior experience as a physician and health advocate. Democrats however scrutinized the nomination. […]
read more >

April 9, 2025

EGWP marketplace medicaid Medicare

You may also like